Post-andropause testosterone therapy is a different problem than early low-T treatment: the acute symptoms have already plateaued, so the real decision is format and monitoring cadence, not whether to start.
- Testosterone therapy for andropause works best when the format matches your monitoring needs, not just your schedule.
- Testosterone cypionate injections at home remain the default for post-andropause men needing predictable weekly dosing — Buy for most cases.
- Long-acting testosterone pellets suit men who want fewer clinic touches every 3 to 6 months — Consider, not a first pick.
- An at-home testosterone test kit before starting confirms diagnosis and sets a monitoring baseline — Buy before any prescription decision.
- Enclomiphene only works if the testes still respond to LH signaling — Skip it once andropause has fully suppressed that pathway.
Why this matters
Andropause isn't a single event. It's the slow, decades-long testosterone decline men see starting in their late 30s and 40s, and by the time someone is past the acute drop-off, the clinical picture has usually stabilized into something chronic: low energy, reduced libido, harder recovery from workouts, thicker midsection, flatter mood.
The mistake in 2026 is treating post-andropause TRT like a first-time low-T case. It isn't. Men in this window often have years of comorbidity data — blood pressure trends, A1C numbers, prior lab panels — that should shape the format and monitoring schedule before a prescription gets written.
Who this is for
This guide is for men roughly 50 and older whose testosterone decline is no longer acute but chronic — guys who've had low-normal or below-range labs for a year or more, not someone testing for the first time this month. If you're still in the early comparison phase, TRT for men over 40 covers the earlier decision points; this page assumes you already know your baseline numbers and are choosing between long-term formats.
What to look for in testosterone therapy for post-andropause men
Confirmed diagnosis, not a symptom checklist
Symptoms alone — fatigue, low libido, mood changes — overlap with sleep apnea, depression, and thyroid issues. A post-andropause diagnosis needs two morning total testosterone draws below 300 ng/dL, plus LH and FSH to confirm whether the signal is coming from the pituitary or the testes. Skipping this step is the single biggest reason men end up on therapy that doesn't fix the actual problem.
Monitoring cadence for hematocrit and PSA
Men over 50 carry real cardiovascular and prostate risk that 30-year-olds starting TRT don't. Hematocrit above roughly 54% is a standard threshold where clinicians pause or adjust dosing, and PSA needs a baseline plus follow-up draws at 3 and 12 months. If your provider isn't scheduling this, that's a red flag regardless of how good the treatment sounds.
Format fit for a decades-long commitment
Post-andropause TRT is rarely a short course — it's often a years-long protocol. Weekly injections, twice-monthly pellets, and daily creams all deliver testosterone, but they carry very different logistics: needle comfort, absorption consistency, and how forgiving the format is if a dose gets missed by a day or two.
Comorbidity screening before the first dose
Type 2 diabetes, sleep apnea, and cardiovascular history all change how aggressively a clinician should dose and how often labs get pulled. A man with an A1C over 6.5% needs closer glucose tracking on TRT than one without, since testosterone can shift insulin sensitivity in either direction.
Fertility relevance, even if it feels irrelevant now
Most post-andropause men aren't planning more children, but exogenous testosterone still shuts down natural LH and FSH production, which can shrink testicular volume over time. That's a smaller priority at 55 than at 35, but it's still worth a two-minute conversation before starting.
Licensed clinician review and a real renewal path
A prescription that isn't reviewed by a licensed clinician, with a documented lab history and a clear renewal process, is a liability. Check how a telehealth prescription for hormone therapy actually gets renewed before committing to any provider.
Top picks for post-andropause TRT
Testosterone cypionate injections at home — the workhorse
Weekly or biweekly dosing, typically formulated at 100-200mg/mL, gives the most predictable serum levels of any format and the longest clinical track record. It requires comfort with a small needle and consistent timing, but for men managing a chronic, years-long protocol, that consistency is the whole point. Verdict: Buy for most post-andropause cases where dosing precision matters more than convenience. Full routine details are in testosterone cypionate injections at home.
Long-acting testosterone pellets — the set-it-and-forget-it pick
Pellets get implanted subdermally and release testosterone steadily for 3 to 6 months, cutting clinic touches from 52 times a year down to 2-4. The tradeoff is less dosing flexibility mid-cycle — if labs come back off-target, you're waiting on the next insertion window rather than adjusting next week. Verdict: Consider if your labs have been stable for at least a year and you want fewer logistics, not your first move if you're still dialing in a dose. Details are covered in long-acting testosterone pellets.
An at-home testosterone test kit — the pick that keeps you honest
This isn't a treatment, it's the gate that decides whether treatment is warranted at all. A baseline draw before starting, then a follow-up at 6-8 weeks, catches both under-dosing and hematocrit creep before either becomes a bigger problem. Verdict: Buy before signing on to any format — it's the cheapest safeguard in the entire process. See an at-home testosterone test kit for what the panel covers.
Enclomiphene — the wildcard
Enclomiphene raises LH and FSH to stimulate the body's own testosterone production instead of replacing it directly, which only works if the testes still respond to that signal. For men whose andropause has progressed to primary testicular failure, this pathway is closed, and enclomiphene won't move the needle. Verdict: Consider only if a clinician confirms testicular responsiveness on labs, Skip otherwise.
“If your hematocrit crosses 54%, the format matters less than the monitoring schedule.”
What to avoid
- Twice-weekly clinic-only injections with no home delivery option — fine for a 35-year-old with flexible time, a real burden for a 58-year-old managing this alongside other chronic care.
- Any compounded product without a licensed clinician reviewing your labs first — post-andropause men have more comorbidity risk, so this isn't the place to skip oversight.
- Providers who don't ask about PSA or hematocrit history — if that question never comes up before a prescription, that's the wrong provider, not the wrong drug.
Verdict comparison
| Format | Dosing frequency | Monitoring load | Best for | Verdict |
|---|---|---|---|---|
| Testosterone cypionate injections | Weekly or biweekly | Moderate, home-manageable | Men wanting precise, adjustable dosing | Buy |
| Long-acting testosterone pellets | Every 3-6 months | Lower touchpoints, less mid-cycle flexibility | Stable labs, fewer clinic visits | Consider |
| At-home testosterone test kit | Baseline + periodic | N/A — it's the monitoring tool | Everyone before and during TRT | Buy |
| Enclomiphene | Daily oral | Requires LH/FSH confirmation | Men with confirmed testicular responsiveness | Consider/Skip by case |
Ready to start TRT the right way?
Get labs reviewed by a licensed clinician before picking a format.
FAQ
What is andropause and how is it different from menopause?
Andropause is the gradual, decades-long decline in testosterone men experience starting in their late 30s or 40s, unlike menopause, which is a sharper hormonal shift in women over a shorter window. By the post-andropause stage, most men have chronic low-normal testosterone rather than a sudden drop.
What's the best testosterone therapy for post-andropause men in 2026?
Testosterone cypionate injections remain the most widely used format in 2026 because of predictable dosing and decades of clinical data. Pellets are a solid alternative for men with stable labs who want fewer clinic visits.
Is TRT safe for men over 50?
TRT can be safe for men over 50 when hematocrit and PSA are monitored on a regular schedule, since older men carry higher baseline cardiovascular and prostate risk. Safety depends far more on monitoring discipline than on which format is chosen.
Do I need lab work before starting testosterone therapy?
Yes — two morning total testosterone draws below 300 ng/dL, along with LH and FSH, are the standard baseline before any prescription. Skipping this step risks treating symptoms that testosterone therapy won't actually fix.
Can enclomiphene replace TRT for older men?
Enclomiphene only works if the testes still respond to LH and FSH signaling, which some post-andropause men have lost. A clinician needs to confirm testicular responsiveness on labs before enclomiphene is a realistic substitute for direct testosterone replacement.
How often do I need blood work once on TRT?
Most protocols call for follow-up labs at 6-8 weeks after starting, then every 6-12 months once stable, checking hematocrit, PSA, and total testosterone. Men with diabetes or cardiovascular history often need closer intervals.
How much does testosterone therapy cost in 2026?
Costs vary by format, dosing, and whether a provider bundles labs into the price, so check current pricing directly with a telehealth provider before comparing options. Injection-based protocols and pellet insertions typically differ in per-visit versus per-cycle cost structure.
Does testosterone therapy help with weight and body composition after 50?
Testosterone therapy can support lean mass and reduce visceral fat in men with confirmed low testosterone, though it isn't a standalone weight-loss treatment. Results depend on maintaining strength training and diet alongside the therapy.
One last thing
The format debate gets most of the attention, but the number that actually determines long-term safety in post-andropause TRT is hematocrit, not testosterone level — a man dosed "correctly" on paper who skips the 6-month blood draw is taking on more risk than one on a slightly conservative dose who never misses a lab.